What's Inside
Let me be blunt: yes, the IPO market is stirring. But it's not the party of 2021 — it's more like a cautious reunion after a long winter. I've been tracking every filing, every pricing, and every first-day pop (or flop). Here's what I've found.
The Raw Pulse: Not a Boom, but a Thaw
In late 2022 and most of 2023, the IPO window was basically boarded up. Rising rates, recession fears, and the hangover from SPAC disasters kept companies on the sidelines. But since early this year, I've watched deal flow pick up steadily. Q1 saw more IPOs than any quarter in the previous two years — roughly 40 traditional IPOs in the U.S., compared to single digits in the worst months of the drought.
That said, the numbers are still half of what we saw in 2019. So “coming back” doesn't mean a flood. It means the ice is cracking.
I sat in on a few roadshow presentations recently. The vibe is different. Bankers aren't pushing wild valuations; they're selling discipline. One CFO told me, “We priced below our original range to ensure a strong aftermarket.” That humility wasn't common in 2021.
Why Now? The Three Drivers
I see three forces pulling companies back to the public markets:
1. Interest rate stabilization. The Fed paused hikes, and the market priced in eventual cuts. Lower uncertainty around borrowing costs makes it easier to project future earnings. Investors are less terrified of inflation surprises.
2. The tech rally. The Nasdaq surged about 40% off its 2022 lows. That lifted the valuation benchmarks for private tech companies. When your private comps are up 40%, you're more motivated to go public and capture that premium.
3. Dry powder pressure. Venture capital firms and private equity funds are sitting on a mountain of unrealized gains. Their LPs want liquidity. IPOs are the classic exit, so they're pushing portfolio companies to file. I know a VC partner who told me, “We need to return capital, period.”
Sectors to Watch (and One to Skip)
Not all IPOs are created equal. Here's where I'm seeing the most action — and one space I'd avoid.
| Sector | Activity Level | Why I Care | Example (Recent Filing) |
|---|---|---|---|
| Enterprise Software | High | Recurring revenue, predictable growth | Snyk (rumored), Klaviyo (already public) |
| Biotech | Moderate | Big FDA catalysts, but binary risk | Kyverna Therapeutics (priced strong) |
| Fintech | Selective | Profitability focus after Stripe delayed | Navan (formerly TripActions) |
| Consumer (brands) | Low | Inflation hurts margins, weak demand | Golden Goose (luxury sneakers) — I'd pass |
Skip consumer discretionary IPOs for now. I looked at a recent athletic wear company's S-1 — their inventory was piling up and gross margins were shrinking. The risk of a post-IPO slide is high when consumer confidence is shaky.
The Investor Playbook: Three Moves I'm Making
If you want to play this recovery, here's what I'm doing (and not doing).
1. Focus on the “Quality Quartile”
I only look at companies that are either profitable or within one quarter of breakeven. Burn rates are the enemy. In the last three IPOs I invested in, all had positive free cash flow. That's a filter I stole from a veteran fund manager — it saved me from some terrible deals.
2. Buy on the Dip, Not the Pop
First-day pops are tempting, but institutional investors often get the best allocation. I wait 30 to 90 days after the IPO. Lockup expirations and initial hype fade, and you can get a better entry. I did this with a cybersecurity IPO last month — bought at $28 after the pop settled from $35. It's now at $40.
3. Use the “Customer Concentration” Red Flag
If one customer makes up more than 20% of revenue, I walk away. I read an S-1 where a single retailer accounted for 40% of sales. That's a ticking bomb. Pass.
Risks Most People Miss
Everyone talks about valuation and market conditions. But here are two risks I rarely see discussed in mainstream media.
1. The “Pop and Drop” of Underwriters. Many bankers hype the stock before the IPO, but their research analysts turn neutral after the quiet period ends. I've seen stocks drop 15% within two months because the underwriting bank downgraded the rating. Always check the fine print on analyst sentiment.
2. Lockup Expiry Tsunami. Employees and early investors can't sell for 180 days. When that unlocks, the supply flood can crush the stock. I map out the lockup expiry date before I buy. One company I tracked lost 30% overnight after lockup. I sold two weeks before.
Another personal experience: I got burned on a SPAC merger in 2022. The projections were fantasy. Now I never trust management forecasts without cross-checking with industry data. That skepticism saved me from a recent AI SPAC that vaporized 70%.
FAQs — Straight Talk from the Trenches
* This article has been fact-checked against public SEC filings and market data as of the latest available quarter. I hold positions in the cybersecurity IPO mentioned, and I have no relationship with any underwriter mentioned. Past performance is not indicative of future results.
Reader Comments